Article info

PDF
Oral antiviral therapy for hepatitis B: the case of besifovir, a new kid on the block with a long way to go

Authors

  1. Correspondence to Dr Pietro Lampertico, 1st Division of Gastroenterology, “A.M. e A. Migliavacca” Center for the Study of Liver Disease, Fondazione IRCCS Ca’ Granda—Ospedale Maggiore Policlinico, Università degli Studi di Milano, Via F Sforza 35-20122 Milan, Italy; pietro.lampertico{at}unimi.it
View Full Text

Citation

Lampertico P
Oral antiviral therapy for hepatitis B: the case of besifovir, a new kid on the block with a long way to go

Publication history

  • Received October 4, 2013
  • Revised October 7, 2013
  • Accepted October 8, 2013
  • First published October 25, 2013.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.